NeueHealth (NEUE) Stock Price, News & Analysis

Company Overview

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.

Key Stats

• Today's Range: $4.95 to $4.97
• 50-Day Range: $4.66 to $5.96
• 52-Week Range: $4.66 to $16.59
• Volume: 1,824 shs
• Average Volume: 9,905 shs
• Market Capitalization: $40.99 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.00
• Consensus Rating: Hold

NeueHealth Stock Analysis - MarketRank™

NeueHealth scored higher than 70% of companies evaluated by MarketBeat, and ranked 332nd out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

NeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

NeueHealth has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of NeueHealth is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of NeueHealth is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.06% of the float of NeueHealth has been sold short.

Short Interest Ratio / Days to Cover

NeueHealth has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NeueHealth has recently decreased by 7.83%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

NeueHealth does not currently pay a dividend.

Dividend Growth

NeueHealth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.06% of the float of NeueHealth has been sold short.

Short Interest Ratio / Days to Cover

NeueHealth has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NeueHealth has recently decreased by 7.83%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $451.00 in company stock.

Percentage Held by Insiders

64.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

NEUE Stock Analysis - Frequently Asked Questions

How have NEUE shares performed this year?

NeueHealth's stock was trading at $6.53 at the beginning of the year. Since then, NEUE stock has decreased by 24.2% and is now trading at $4.95.
View the best growth stocks for 2024 here.

Who are NeueHealth's major shareholders?

NeueHealth's top institutional shareholders include Partners Group Holding AG (1.07%). Insiders that own company stock include Jay Matushak, Tomas Orozco, Jeffrey J Scherman and Jeffery Michael Craig.
View institutional ownership trends.

How do I buy shares of NeueHealth?

Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of NeueHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 3/05/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Hospital & medical service plans
• Sub-Industry: N/A
• Current Symbol: NYSE:NEUE
• Previous Symbol: NYSE:NEUE
• CUSIP: N/A
• CIK: 1671284
• Web: www.brighthealthgroup.com
• Phone: 612-238-1321
• Fax: N/A
• Employees: 1,252
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $8.00
• High Stock Price Target: $8.00
• Low Stock Price Target: $8.00
• Potential Upside/Downside: +61.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($51.16)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-1,151,450,000.00
• Net Margins: -36.28%
• Pretax Margin: -11.79%
• Return on Equity: -6.40%
• Return on Assets: 8.45%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.68
• Quick Ratio: 0.68

Sales & Book Value

• Annual Sales: $1.16 billion
• Price / Sales: 0.04
• Cash Flow: $61.88 per share
• Price / Cash Flow: 0.08
• Book Value: ($163.05) per share
• Price / Book: -0.03

Miscellaneous

• Outstanding Shares: 8,280,000
• Free Float: 2,958,000
• Market Cap: $40.99 million
• Optionable: N/A
• Beta: 0.76